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Abstract: The currently available methods for the diagnosis of dry eye are still far from being 
perfect for a variety of reasons. This review attempts to highlight the advantages and disad-
vantages of both traditional tests (such as Schirmer’s test, break-up time and ocular surface 
staining) and innovative noninvasive procedures, including tear meniscus height measurement, 
corneal topography, functional visual acuity, tear interferometry, tear evaporimetry and tear 
osmolarity assessment.
Although any ophthalmologist and eye care practitioner is familiar with conventional 
methods such as Schirmer’s test and break-up time (BUT), diagnosing dry eye is still 
a challenging task for several reasons:
1.  The term “dry eye” includes a wide spectrum of alterations of the ocular surface 
with different etiology and pathophysiology; as a consequence, even the deﬁ  nition 
of dry eye is still debated, as demonstrated by the fact that in 2006 a panel meeting, 
including some of the most experienced subspecialists, recommended using the 
designation of “dysfunctional tear syndrome” (DTS) instead of dry eye, as “it is 
sufﬁ  ciently broad to encompass the myriad of etiologies while still representing a 
common denominator among them” (Behrens et al 2006). However, a few months 
later, the updated deﬁ  nition proposed by the International Dry Eye Workshop 
(DEWS) did not refer to DTS and considered dry eye as a part of the ocular surface 
disease, which includes both aqueous deﬁ  cient and evaporative dry eye, lid related 
diseases (such as meibomian gland dysfunction (MGD) and anterior blepharitis), 
allergic conjunctivitis and other inﬂ  ammatory, infective o iatrogenic conditions. 
According to the DEWS deﬁ  nition, dry eye is “a multifactorial disease of the tears 
and ocular surface that results in symptoms of discomfort, visual disturbance, and 
tear ﬁ  lm instability with potential damage of the ocular surface. It is accompanied 
by increased osmolarity of the tear ﬁ  lm and inﬂ  ammation of the ocular surface 
(DEWS 2007).
2.  There is no universal consensus on the guidelines for such a diagnosis and a gener-
ally agreed “gold standard” does not exist. The lack of consensus is due in turn to 
the lack of well-deﬁ  ned cut-off values enabling a distinction to be made between 
healthy and affected eyes. The main difﬁ  culty in establishing cut-off values is that 
there is no dichotomous separation between non-dry and dry eyes. Rather, there is 
a continuum of susceptibility, and environmental inﬂ  uences (temperature, aridity, 
wind, irritants, contact lens wear, etc.) are important in determining the degree of 
disease manifestation: it follows that the cut-off point for diagnosis is a synthetic 
and semi-arbitrary choice, which should be based on a consideration of the relative 
consequences of having too many false-positives or too many false-negatives, and 
may vary depending on clinical circumstances.Clinical Ophthalmology 2008:2(1) 32
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3.  Most diagnostic tests are still poorly standardized, which 
often makes it difﬁ  cult to compare studies by different 
authors (Foulks 2003).
4.  The ocular surface environment is very sensitive to any 
external stimulus and most diagnostic tests are overly 
invasive, so that the resulting measurements can be 
easily influenced by mechanical, chemical or other 
stimulations (Yokoi and Komuro 2004).
5.  Although many noninvasive tests have been developed 
over the last decade, they have not found wide applica-
tion, either because they are not commercially available 
in all parts of the world (eg, DR1, Kowa) or they are 
considered too expensive (eg, StratusOCT, Carl Zeiss), or 
because of other reasons which make them less appealing 
than the traditional tests.
6.  Since the ocular surface sensitivity is reduced in advanced 
ocular surface disease (Adatia et al 2004), and the tests 
currently used are far from being perfect, these are poorly 
associated with subjective symptoms (Bjerrum 1996; 
Schein et al 1997; Hai et al 1998; Pﬂ  ugfelder et al 1998; 
Nichols, Nichols, et al 2004; Lin et al 2005).
Additional difﬁ  culties arise because tests are used for 
a variety of purposes (such as, for example, diagnosing 
dry eye in everyday clinical practice, assessing eligibility 
in a clinical trial, or following quantitative changes during 
a clinical trial) and a given test may not be appropriate 
for all circumstances; ﬁ  nally, we should keep in mind 
that many clinical and experimental studies about dry eye 
diagnosis are limited by selection bias, due to the fact that 
the test population may have been classiﬁ  ed as affected 
or non-affected based on the same tests being evaluated 
for efﬁ  cacy; similarly, the performance of a new test may 
be compromised when the test is assessed in a sample of 
dry eye patients who have been diagnosed by means of 
unestablished criteria.
Given the unsatisfactory results provided by the cur-
rently available tests, an increasing number of procedures 
have been recently described. A detailed list of these tests 
and their intended use is presented in Table 1. The aim of 
this article is to summarize the present knowledge about dry 
eye diagnosis and highlight the pros and cons of the most 
interesting conventional and innovative tests.
Evaluation of tear secretion
Schirmer’s test
The Schirmer test, ﬁ  rst described in 1903 by Schirmer, is 
still the method most commonly used to evaluate aqueous 
tear production (Schirmer 1903). The original test used 
blotting paper cut into strips measuring 35 by 5 mm, which 
were hooked over the lower lid margin. Schirmer initially 
described three methods: (1) inserting the strip for 5 minutes, 
then measuring the length of paper wetting in millimeters; 
(2) anesthetizing the eye before performing the test and 
stimulating the nasal mucosa with a hair brush; (3) similar 
to the second method, but having the patient look at the 
sun instead of relying on nasal irritation. Unfortunately, 
the Schirmer test has many disadvantages, including low 
reproducibility, sensitivity and speciﬁ  city, frequent discom-
fort, difﬁ  culty of performing the test in children, potential 
injury to the conjunctiva and cornea, lack of a deﬁ  nite site of 
paper placement in the conjunctival sac, uneven absorption 
of tears by the paper strip, uncertainty whether the quantity 
of ﬂ  uid absorbed by paper strips is directly proportional to 
the wetted length, difﬁ  culty of evaluating the wetting length 
in cases where the leading edge of the wetted area is round 
or oblique and lack of control over reﬂ  ex lacrimation (Cho 
and Yap 1993).
There are several variations in the technique of perform-
ing the Schirmer test. Such variations regard the paper type 
and position, eye position (closed or open), anesthetic use 
(with or without) and reﬂ  ex stimulation. As noted previ-
ously, Schirmer ﬁ  rst introduced this test in 1903. Several 
investigators subsequently modiﬁ  ed the procedure. In 1953, 
deRoetth modiﬁ  ed it by changing the paper to Whatman 
standard No. 41 ﬁ  lter paper and in 1961 standardized 
Schirmer test strips were introduced for the ﬁ  rst time by 
Halberg and Berens (De Roetth 1953; Halberg and Berens 
1961). Regarding the position of the paper placed on the 
lid margin, many investigators have suggested different 
places, including near the puncta (Henderson and Prough 
1950), at the medial third of the lower lid (Henderson and 
Prough 1950; Wright and Meger 1962), at the middle of 
the lower lid (Hanson et al 1975; Patel and Farrell 1987), 
at the junction of the medium and lateral third of the lower 
lid (Halberg and Berens 1961), or within the lateral third 
of the lid margin (Jones 1966; Doughman 1973; Shapiro 
and Merin 1979). However, reports have revealed no dif-
ferences in relation to whether the paper is placed at the 
medial or lateral site of the lower lid margin (Jones 1972; 
Loran et al 1987).
Topical anesthesia may or not may be applied; in the 
former case residual ﬂ  uid should be blotted out of the inferior 
fornix. The patient is advised to avoid both squeezing the lids 
and looking up, and should blink naturally (Doughman 1973; 
Shapiro and Merin 1979; Clinch et al 1983), though some 
reports recommend closing the eyes (Wright and Meger 1962; Clinical Ophthalmology 2008:2(1) 33
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Prause et al 1982; Pandher et al 1982). It is not clear whether 
the closure and/or the position of the eyes inﬂ  uences the test 
(Loran et al (1987), for example, found no differences in the 
test results when the eyes were closed or open) and some 
investigators do not give importance to these issues (Nelson 
1982; Pandher et al 1985).
At present, the ﬁ  rst of the three original Schirmer test 
methods is still popular and is referred to as Schirmer test I. It 
measures total tear secretion, including reﬂ  ex and basal tears. 
Schirmer test II, which is performed in anesthetized eyes, 
demonstrates reﬂ  ex tears, though a cotton-tipped applicator 
is now used in the place of a hair brush to stimulate the 
reﬂ  ex (Doughman 1973). Jones introduced another technique 
similar to Schirmer test I. It is performed in anesthetized 
eyes without stimulating any reﬂ  ex and claims to measure 
basal tears (Hanson et al 1975). However, the concept of 
basal tears is questionable. “Pure” basal tears might not be 
measured even in anesthetized eyes, where stimulation of the 
Table 1 Clinical and experimental tests to diagnose dry eye and their intended use. References are given only for those tests that are 
not described in the present review
Intended use Test Reference
1. Tear secretion assessment
 1a.  Reﬂ  ex secretion Schirmer I (no anesthesia)
  1b. Basic secretion Thread methods
Schirmer with anesthesia
One-minute Schirmer
2. Tear clearance assessment Fluorescein clearance test
Tear function index
Fluorophotometry Afonso et al 1999
3. Ocular surface damage assessment
  3a. Staining Fluorescein staining
Rose bengal staining
Lissamine green staining
  3b. Citology Impression citology
Brush cytology
Flow cytometry in impression citology
Confocal microscopy
Tatcher et al 1977
Tsubota et al 1990
Brignole et al 2004
Erdelyi et al 2007
4. Tear ﬁ  lm stability assessment Tear break-up time
Non-invasive tear break-up time
Tear ﬁ  lm Stability Analysis System (TSAS)
Wavefront aberrometry
Laser scanning microscopy
Functional visual acuity
Tear ﬁ  lm interferometry
5. Tear volume assessment Tear meniscus measurement
6. Lipid layer assessment
  6a. Precorneal lipid layer assessment Tear ﬁ  lm interferometry
  6b. Lid margin lipids assessment Meibometry Chew et al 1993
  6c. Meibomian glands assessment Meibography Robin et al 1985
7. Tear evaporation assessment Evaporimeter
Closed chamber
Ventilated chamber
8.  Tear ﬁ  lm chemical properties
assessment
  8a. Tear osmolarity Depression of freezing point
Vapor pressure osmometry
Conductivity (Ocusense)
 8b.    Biochemical analysis of tear
composition 
Lacrimal gland and serum proteins analysis
Mucins analysis
Lipids analysis
Ohashi et al 2006
Ohashi et al 2006
Ohashi et al 2006Clinical Ophthalmology 2008:2(1) 34
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lid margin could increase the turnover rate by up to 300% 
(Tabak 1972).
Sensitivity, speciﬁ  city, reliability 
and repeatability
A wide range of sensitivity and speciﬁ  city values has been 
reported for the Schirmer test. This variability is thought to 
derive from the paper’s contact with the eyelashes for a long 
period (5 minutes), which elicits reﬂ  ex tearing that cannot be 
suppressed by topical anesthetics (Jordan and Baum 1980). 
In addition, the change in light, humidity and temperature 
and patient anxiety may interfere with the tear reﬂ  ex (Nichols, 
Mitchell, et al 2004). These factors similarly help to explain 
the large discrepancies in the reported repeatability of the 
Schirmer test. Feldman and Wood (1979) found that in the 
same person the Schirmer test values with anesthesia could 
range from 11 to 31 mm when repeated at the same time of 
day for 30 or 31 consecutive days. Nichols et al reported 
similar results also for the Schirmer test without anesthesia, 
although a moderate repeatability was observed in the lower 
score range, especially where Schirmer values were lower 
than 10 mm (Nichols, Mitchell, et al 2004).
Since the Schirmer test does not provide good repeat-
ability, due both to the limitations of the test itself and to 
the above-mentioned variations on the original techniques, 
the cut-off values likewise show considerable differences, as 
do the sensitivity and speciﬁ  city rates published in different 
reports (Table 2).
Mean Schirmer test values in healthy eyes exhibit wide 
variability among different investigators, ranging from 8.1 to 
33.1 mm without anesthesia and from 3.5 to 11.9 mm with 
anesthesia (Wright and Meger 1962; Lamberts et al 1979; 
Shapiro and Merin 1979; Jordan and Baum 1980; Nelson 
1982; Pandher et al 1985; Lee and Kee1988). Lamberts 
found that 15% of normal volunteers obtained Schirmer 
test values from 0 to 3 mm (Lamberts et al 1979). Topical 
anesthesia has shown to reduce Schirmer test values by 40 to 
56.5% compared to unanesthetized eyes (Pandher et al 1985, 
Lamberts et al 1979). Schirmer test values tend to decrease 
with age and reduced corneal and conjunctival sensitivity 
(Wright and Meger 1962, Jordan and Baum 1980), whereas 
some investigators have found no decrease in tear production 
as determined by Schirmer testing in patients of advanced 
age (Lamberts et al 1979).
In summary, the Schirmer test without anesthesia can be 
reasonably considered a valid option only for severe dry eye 
(Tsubota, Xu, et al 1996), where it shows moderate repeat-
ability, but it lacks sufﬁ  cient sensitivity and is too variable 
to be used in the diagnosis or grading of milder anomalies. 
No deﬁ  nitive conclusions can be drawn about the ability 
of Schirmer’s test with anesthesia to detect and grade mild 
cases of dry eye.
Table 2 Schirmer’s test variants and cut-off values
Author (year)  Test  Topical  Sample size  Time   Stimulation  Cut off value  Sensitivity/ 
  anesthesia    (minutes)    (mm)  speciﬁ  city)
Schirmer (1903)  I  –  –  5   –  –  Not available
  II  +    5   Nasal (hair brush)    Not available
  III +  –  5    Light   Not  available
Van Bijsterveld (1969)  I  –  –  5   –  5.5  85%/83%
Jones (1966)  II  +  –  5   –  10  Not available
Danjo (1997)  I  –  100 eyes  5   –  5  80%/53%
        –  10  88%/35%
Nelson (1982)  Short Schirmer I   –  30 subjects  1   –  6  Not available
Bawazeer and  Short Schirmer I  +  60 eyes  1   –  2  100%/not 
Hodge (2003)  with anesthesia          (severe dry eye)  available
          3–6  80%/not 
          (mild-moderate  available
          dry  eye)
Hanano et al (1983)   Phenol red thread  –    15 seconds  –  10  Not available
Prabhasawat and  Fluorescein Clearance  +    1  Nasal stimulation  3  Not available
Tseng (1998)  Test*         in the last strip
Afonso et al (1999)  Fluorescein Clearance   –  80 subjects  15  –  3.07 ± 0.61  85%/80%
  Test           (log tear ﬂ  uorescein 
 (Fluorophotometry)          concentration) 
Xu et al (1995)  Tear Function Index  +  352 subjects  5 minutes  –  34  78.9% (91.8%)
*Serial measurements with Schirmer strips for 30 minutes.Clinical Ophthalmology 2008:2(1) 35
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Variants of the Schirmer test
Since reduced repeatability stems from reﬂ  ex tearing, which 
is in turn inﬂ  uenced by the paper width and lengthy contact 
time, many authors have tried to improve the Schirmer test 
by focusing on these points. Nelson et al and Bawazeer et al 
suggested performing a 1-minute Schirmer test for greater 
convenience and to reduce errors (Nelson 1982; Bawazeer 
and Hodge 2003). Hamano et al in describing the beneﬁ  ts of 
the phenol red thread test, noted that substituting paper with 
thread served to reduce the contact surface, thus minimizing 
reflex tearing and improving accuracy (Hamano et al 
1983). Prabhasawat and Tseng argued that the ﬂ  uorescein 
clearance test, in which Schirmer paper was used 3 times 
for 1 minute at 10-minute intervals, reduced reﬂ  ex tears and 
could reliably demonstrate tear dynamics (Prabhasawat and 
Tseng 1998).
1-minute Schirmer test
In order to minimize ocular discomfort and save time, 
Nelson proposed shortening the standard Schirmer I test 
by performing it in 1 minute instead of 5 (Nelson 1982). 
The cut-off value was established as 6 mm. Bawazeer 
and Hodge also demonstrated that the 1-minute Schirmer 
test with anesthesia correlated highly with the 5-minute 
Schirmer test with anesthesia (Bawazeer and Hodge 2003). 
In severely dry eyes, a 5-minute Schirmer value equal to 
or less than 5.5 mm highly correlated with 2 mm in the 
1-minute Schirmer test, while in mildly to moderately 
dry eyes a 5-minute Schirmer value between 5–10 mm 
corresponded with 3–6 mm in the 1-minute Schirmer test 
(Table 2).
Thread method
With the aim of reducing conjunctival and lid irritation, 
Kurihashi et al modiﬁ  ed the Schirmer test by using ﬁ  ne 
thread instead of Whatman ﬁ  lter paper (Kurihashi et al 
1977). A ﬁ  ne white thread, 0.25 mm in diameter, 70 mm 
in length and stained with ﬂ  uorescein at one end (3 mm), 
is inserted into the temporal unanesthetized conjunctival 
sac for 30 seconds; the wetted portion of the thread turns 
yellow and the length of the wetted thread is then measured. 
Hamano et al adapted this test into “the phenol red thread 
test” (PRT), which uses a cotton thread impregnated with 
phenol red dye (Hamano et al 1983). The pH of the tears 
turns the color of the dye from yellow to red. The technique 
in the PRT is the same as in the ﬁ  ne thread test except that 
the thread is inserted for only 15 seconds. Both tests are 
minimally invasive and stimulate less reﬂ  ex tearing. A 
cut-off value of 10 mm of wetting is used to diagnose dry 
eyes (Table 2). However, the advantages of this test above 
the Schirmer test are still a matter of controversy. This test 
has been reported by some to be more sensitive than the 
Schirmer test (Ashell and Chiang 1987). However, Yokoi 
et al found that the Schirmer test signiﬁ  cantly correlated 
with the tear meniscus radius in dry eye patients, while the 
PRT did not show such a correlation (Yokoi et al 2000); 
similar ﬁ  ndings were reported by Tomlinson et al who 
failed to demonstrate a correlation between the values of the 
PRT and those of the tests measuring either tear secretion 
or volume (Tomlinson et al 2001). In other words, it is not 
yet clear what does the PRT actually measure.
Fluorescein clearance tests
The groups led by Tseng and Tsubota modiﬁ  ed the Schirmer 
test in order to assess the tear clearance or turnover, ie, the 
combination of tear secretion and drainage.
Fluorescein clearance test (FCT)
Originally, the FCT consisted in serial measurements of the 
1-minute Schirmer test performed every 5 minutes over a 
period of 30 minutes after applying 0.5% proparacaine and 
5 μl of Fluoress® (0.25% ﬂ  uorescein combined with 0.4% 
benoxinate hydrochloride) (Prabhawasat and Tseng1998, 
Pﬂ  ugfelder et al 1998). Both the wetting of the strip and 
dye disappearance were recorded. For the last strip, nasal 
stimulation was performed using a cotton tip to induce reﬂ  ex 
tears. This test has since been simpliﬁ  ed by inserting one set 
of Schirmer papers for each 10-minute interval. A normal 
value of tear secretion is obtained if the wetting length is 
equal to or greater than 3 mm at the 10-minute interval. 
Clearance is deﬁ  ned as normal if the dye cannot be detected 
at the 20-minute interval. This test is intended to evaluate 
basal tears, reﬂ  ex tears and tear clearance all at the same 
time (Figure 1). As a major advantage, it is inexpensive and 
relatively easy to perform, as all the necessary materials are 
readily available in the clinical setting. The disadvantages in 
terms of variability, sensitivity and speciﬁ  city for tear secre-
tion evaluation are similar to conventional Schirmer’s test, 
where paper’s touching eyelashes, eliciting reﬂ  ex tearing, 
cannot be suppressed by topical anesthesia (Jordan and Baum 
1980). Finally, since tear secretion assessment may be biased 
by the addition of anesthetic drops, blotting the conjunctival 
fornix with the corner of a tissue before ﬂ  uorescein instilla-
tion is recommended to provide a more consistent baseline 
from which to begin measurement of secretion, as the excess 
instilled solution is absorbed (Foulks 2003).Clinical Ophthalmology 2008:2(1) 36
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Tear function index (TFI)
The original TFI test is similar to the Schirmer test with 
anesthesia, but involves the addition of a 10-μl drop of 0.5% 
ﬂ  uorescein. Five minutes after instillation of ﬂ  uorescein into 
the conjunctival fornix, the length of the wetted portion is 
measured and the intensity of dye staining is compared to the 
standard strip colors. The tear clearance rate (TCR) is deter-
mined based on the rate at which the color of the ﬂ  uorescein 
dye fades and is graded as 1, 1/2, 1/4, 1/8, 1/16 1/32, 1/64, 
1/128 and 1/256. The TFI value is equal to the value of the 
Schirmer test with anesthesia divided by the TCR. Patients 
who have ATD and delayed tear clearance will have a low 
TFI value (Xu et al 1995). From a theoretical point of view, 
the TFI test may suffer from the same disadvantages of 
conventional Schirmer’s test (just mentioned for the FCT); 
nevertheless, Xu and Tsubota demonstrated that it is consis-
tent with measurements obtained by ﬂ  uorophotometry (Xu 
and Tsubota 1995). A modiﬁ  ed version of the TFI has been 
Fluorescein Clearance Test (FCT)
Normal DTC
10
10 10
10 20
20 20
20 30  min
30  min 30  min
30  min
ATD  s  R ATD  c  R
Figure 1 Fluorescein clearance test results. The black line indicates the portion of the strip wetted by tears. 1A: in healthy subjects, the wetting length is 3 mm and ﬂ  uo-
rescein stains only the ﬁ  rst strip, whereas the wetted portion increases in the second and third strips. 1B: in case of delayed tear clearance, ﬂ  uorescein stains all three strips 
and normal wetting length is observed. 1C: in the event of aqueous tear deﬁ  ciency without reﬂ  ex tearing, the wetting length is nearly 0 mm for all 3 strips; 1D: in the event 
of aqueous tear deﬁ  ciency with reﬂ  ex tearing, the wetting length of the ﬁ  rst strip is 0 mm and increases especially in the third strip, when nasal stimulation is performed.Clinical Ophthalmology 2008:2(1) 37
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proposed later by Kaye et al who suggest to use prepared 
strip containing 1.3 μl of 0.5% ﬂ  uorescein, since instilling 
10 μl of ﬂ  uorescein increases the tear volume and may act 
as a stimulant, thus limiting the applicability of the TFI test 
(Kaye et al 2001).
Ocular surface staining
Fluorescein staining
Fluorescein sodium has been used to detect corneal epithelial 
defects since the end of the nineteenth century and currently 
represents one of the most frequently adopted methods for 
studying dry eye (Behrens et al 2006, Turner et al 2005). 
It lacks intrinsic cellular toxicity and photodynamic action 
(Feenstra and Tseng1992a).
Fluorescein can be instilled either by means of an impreg-
nated paper strip (wetted with a drop of saline) or a 1% or 2% 
sterile unpreserved unit-dose preparation. The latter allows 
the clinician to deliver a more precise amount of dye onto 
the ocular surface. Microdrops (eg, 2 or 3 μl) obtained using 
a pipette are recommended, as larger amounts of dye may 
not be sufﬁ  ciently diluted in very dry eyes, resulting in less 
than optimal ﬂ  uorescence (Bron et al 2003).
Fluorescein is highly water soluble at physiologic pH 
and hence poorly penetrates the lipid layer of the epithelium 
and does not readily stain normal corneas or pass through 
to the aqueous humor. Corneal and conjunctival surfaces 
are stained whenever there is a disruption of cell-to-cell 
junctions (Feenstra and Tseng 1992a). Pseudo-staining may 
occur when ﬂ  uorescein dye pools in indented, but healthy 
epithelium.
The clinical appearance of ﬂ  uorescein staining in dry 
eye includes a wide range of corneal superﬁ  cial punctate 
epithelial erosions. Initially, these erosions are usually seen 
in the lower third of the cornea and then may spread over 
the entire corneal surface. In dry eyes ﬂ  uorescein staining 
may also be seen on the conjunctival surface. Yokoi and 
Kinoshita reported that conjunctival damage precedes that 
of the cornea and is more severe (Yokoi and Kinoshita 1998). 
However, detecting ﬂ  uorescein staining of the conjunctival 
epithelium can be more difﬁ  cult because of the poor scleral 
contrast. Staining intensity can be better appreciated if a yel-
low (blue-free) barrier ﬁ  lter (eg, Wratten 12 yellow) is used 
in front of the ocular eyepieces. This enhances the visualiza-
tion of ﬂ  uorescein staining over the conjunctiva even in mild 
cases, thus improving the ability to diagnose conjunctival 
damage in early dry eye (Koh et al 2003).
Since SPK superﬁ  cial punctate epithelial erosions may be 
related to several causes (eg, drug toxicity, LASIK-induced 
neurotrophic epitheliopathy, corneal conjunctivalization), 
corneal ﬂ  uorescein staining cannot be considered a speciﬁ  c 
sign of dry eye (Savini et al 2006a). Nor can it be considered 
a very sensitive measure, as it may be detected in only 10% 
of dry eyes and does not seem to be associated with dry eye 
symptoms (Schiffman et al 2000; Nichols, Nichols, et al 
2004; Lin et al 2005).
Rose bengal staining
Since its ﬁ  rst reported use on the eye almost one century 
ago, Rose Bengal (RB), the 4,5,6,7-tetrachloro-2’,4’,5’,7’-
tetraiodo derivative of ﬂ  uorescein, has been widely used to 
detect damage to the ocular surface epithelium (mainly on 
the conjunctiva, due to poor contrast on the cornea). Tradi-
tionally RB has been thought to stain dead or desquamated, 
but not healthy epithelial cells; this concept was introduced 
in the 1930s by Sjögren and later reiterated by Passmore 
and King, but no direct evidence was ever provided. It was 
further reinforced by Norn in the 1960s (Passmore and King 
1954; Norn 1962; Norn 1969a).
The conventional understanding of RB’s staining proper-
ties was reinterpreted by Feenstra and Tseng, who showed 
that RB staining ensues when the ocular surface is not 
adequately protected by the tear ﬁ  lm (Feenstra and Tseng 
1992a, 1992b). In vitro studies on human corneal-limbal 
epithelial cells have since demonstrated the important role 
of membrane-associated mucins (in addition to secreted 
mucins) in blocking RB staining. It is likely that in patients 
with dry eye RB staining occurs in areas lacking these mucins 
(Argüeso et al 2006).
Feenstra and Tseng also highlighted the intrinsic toxicity 
of RB, which induces an instant loss of vitality (as shown by 
immediate cellular morphologic changes, subsequent loss of 
cellular motility, cell detachment and death). This intrinsic 
toxic effect is augmented by light exposure (Feenstra and 
Tseng 1992a). Kim and Foulks provided evidence of RB 
toxicity also on human corneal epithelial cells (Kim and 
Foulks 1999).
Methods of RB instillation vary among clinicians. Most 
instill a drop (20–25 μl) of 0.5%–1% dye (Pﬂ  ugfelder et al 
1998; Bron et al 2003; Horwath-Winter et al 2003) and 
suggest waiting a few minutes before examination (Pﬂ  ug-
felder et al 1998; Kim 2000); a brief rinse with saline can be 
added before observing the ocular surface at the slit-lamp. 
Using RB drops seems to give more reliable results than 
impregnated strips, since the latter, though still widely used 
(Tamer et al 2005), do not enable precise control over the 
volume of dye used (Snyder and Paugh 1998; Kim 2000). Clinical Ophthalmology 2008:2(1) 38
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This is probably the reason why a poor repeatability of 
RB staining was found in a study where wetted strips were 
used (Nichols, Mitchell, et al 2004). Alternatively, the best 
solution may be the use of a pipette to instill a microdrop 
of dye (either 1 or 5 μl): this reduces subjective irritation 
while maintaining sufﬁ  cient staining (Schein et al 1997). 
The amount of staining is dose-dependent and instilling a 
5 μl drop can lead to different results than instilling a 25 μl 
drop (Bron 2001).
Some ophthalmologists prefer to instill topical anesthetic 
before RB in order to reduce the typical burning sensation 
(Schein et al 1997; Bron 2001), whereas a number of authors 
have warned against this practice, as it may cause false posi-
tive staining.
Rose Bengal staining can be detected in different types 
of dry eye. Patients with SS-related ATD show the highest 
degree of staining, but also patients with non-SS ATD and 
meibomian gland dysfunction have higher staining scores 
than patients without dry eye (Pflugfelder et al 1998). 
However, the association between RB staining and dry eye 
has not yet been fully characterized, as RB staining can also 
be observed in asymptomatic patients (Schein et al 1997; 
Khan-Lim 2004) and seems to lack a clearly deﬁ  ned relation-
ship with subjective symptoms (Schein et al 1997; Lin et al 
2005). RB staining of the ocular surface thus does not seem 
to have sufﬁ  cient sensitivity and speciﬁ  city to be used alone 
as a marker for dry eye diagnosis.
In addition, RB stains Marx’s line (i.e., the mucocutaneous 
junction of the lid margin) in most eyes (Figure 2). The clini-
cal and pathophysiological meaning of RB staining of Marx’s 
line remains poorly understood (Norn 1966).
Rose Bengal staining in dry eyes can show differ-
ent patterns. In early stages of disease it may be absent 
or limited to the nasal bulbar conjunctiva within the 
exposure zone. In moderate disease, both the nasal and 
temporal bulbar conjunctiva stain within the exposure 
zone, although staining is usually still more evident in 
the nasal conjunctiva. As the disease progresses, staining 
Figure 2 Rose Bengal staining of the Marx line.Clinical Ophthalmology 2008:2(1) 39
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can also be observed in the inferior cornea and eventually 
the whole cornea can stain. Typically, RB staining is 
not uniform but is characterized by multiple small dots 
(Figure 3).
Rose Bengal has also been shown to stain the ocular 
surface in a variety of diseases that may not necessarily be 
associated with dry eye. In conjunctivochalasis RB staining 
can be observed along the redundant conjunctival folds, 
the area above these folds, the adjacent lid margin and 
the conjunctival non-exposure zone (Di Pascuale, Espana, 
et al 2004). In lipid tear deﬁ  ciency caused by noninﬂ  amed 
meibomian gland dysfunction RB staining preferentially 
occurs in the non-exposure zone (Lee and Tseng 1997), while 
in superior limbic keratoconjunctivitis it can be detected 
in the superior bulbar conjunctiva (Perry et al 2003). In 
LASIK-induced neurotrophic epitheliopathy RB staining 
typically affects the cornea (Wilson and Ambrosio 2001; 
Savini et al 2004). Finally, RB staining can be detected in 
atopic keratoconjunctivitis, herpes simplex keratitis and 
ocular surface neoplasia (Wilson 1976; Holland and Schwartz 
1999; Onguchi et al 2006).
In conclusion, RB staining gives us an idea of how 
damaged the ocular surface is. Several questions, however, 
remain unanswered: (1) what binds RB? (2) Why can it occur 
in asymptomatic eyes and be absent in patients with low tear 
secretion? (3) What is the speciﬁ  city and sensitivity of RB 
staining in the diagnosis of dry eye? (4) What is the meaning 
of Marx’s line staining?
Lissamine green staining
Lissamine green (LG) is a synthetic organic acid dye that 
stains the ocular surface similarly to RB without causing 
stinging. Staining is dose dependent and a minimal dosage 
of 10–20 μl is recommended, since inadequate volume 
results in a weak staining pattern that can be overlooked 
or underestimated. When LG is used, attention should be 
paid to the timing of observation, because an overly hasty 
evaluation is likely to hamper a full understanding of the 
Figure 3 Typical dotted staining of the conjunctiva by rose bengal.Clinical Ophthalmology 2008:2(1) 40
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staining pattern (evaluating the staining too quickly does 
not allow full development of the staining pattern and delay 
in evaluating the stain results in fading of the pattern). 
Ideally the grading should be performed between one and 
four minutes after staining. For a better reading it is also 
essential not to use an intense illumination beam, which 
may reduce the contrast and lead to an underestimation of 
grading (Foulks 2003).
As in the case of the above-mentioned dyes, impregnated 
strips are commercially available.
In the clinical setting, the staining proﬁ  le of LG is 
nearly identical to that of RB and they are considered 
to be interchangeable (Norn 1973; Manning et al 1995; 
McCulley 2003). However, experimental studies have 
detected important differences between LG and RB: the 
former, for example, does not stain healthy corneal epi-
thelial cells, nor does it affect their viability, whereas both 
characteristics are typical of RB (Chodosh et al 1994; Kim 
and Foulks 1999).
Scoring systems
The three most commonly employed methods to grade 
ocular surface staining are the van Bijsterveld system, 
the NEI/Industry Workshop guidelines and the Oxford 
Scheme.
Van Bijsterveld described a scoring system that divides 
the ocular surface into three zones: nasal bulbar conjunctiva, 
temporal bulbar conjunctiva, and cornea. Each zone is evalu-
ated on a scale of 0 to 3, with 0 indicating no staining and 3 
indicating conﬂ  uent staining; the maximum possible score 
with this system is 9 (van Bijsterveld 1969).
The NEI/Industry Workshop guidelines aim to provide 
a more precise regional grading of the cornea and conjunc-
tiva (Lemp 1995). The former is divided into ﬁ  ve sectors 
(central, superior, inferior, nasal and temporal), each of 
which is scored on a scale of 0–3, with a maximal score of 
15. Both nasally and temporally, the conjunctiva is divided 
into a superior paralimbal area, an inferior paralimbal area 
and a peripheral area with a grading scale of 0–3 and with a 
maximal score of 9 for the nasal and temporal conjunctiva.
The Oxford Scheme, which has been specifically 
developed to quantify epithelial damage in case of dry eye, 
uses a chart with a series of panels labeled A–E in order of 
severity (absent, minimal, mild, moderate, severe) (Bron 
et al 2003). The whole exposed ocular surface is considered, 
without separating the cornea and the conjunctiva, and 
the number of dots representing the staining increases 
logarithmically.
Recently, Miyata and coauthors described a novel 
method for grading ﬂ  uorescein staining in SPK. Both area 
and density are graded (respectively from A0 to A3 and 
from D0 to D3) and combined in a single index (Miyata 
et al 2003).
At present, there are no published studies demonstrat-
ing that one grading system is innately better than another. 
A theoretical disadvantage of both van Bijsterveld’s 
system and NEI/Industry Workshop guidelines is repre-
sented by the fact that they are not pure linear scales with 
limited endpoints: for example, the severity of staining 
in grade 3 could encompass a category with a large tail. 
Moreover, they use a more restricted range of scores 
than the Oxford system, which therefore is especially 
valuable for discriminating changes in milder degrees 
of severity while preserving the steps in the more severe 
degrees of staining. A comparative study of the Oxford 
Scheme and the NEI Workshop method conducted in 
patients with moderate dry eye disease demonstrated 
greater discriminative power of the Oxford Scheme in 
this subset of patients (personal communication, Janine 
A. Smith, MD, NIH Workshop on Clinical Trials in Dry 
Eye, May, 2001).
Evaluation of tear ﬁ  lm stability
Break-up time
An unstable tear ﬁ  lm is one of the most common ﬁ  ndings 
in patients with ocular irritation caused either by reduced 
aqueous tear production (SS and non-SS) or an increase in 
tear evaporation, as in the case of MGD. The method most 
frequently used to assess tear ﬁ  lm stability is to measure the 
tear break-up time (TBUT), ie, the time interval between a 
complete blink and the ﬁ  rst appearance of a dry spot in the 
precorneal tear ﬁ  lm after ﬂ  uorescein instillation (Figure 4) 
(Norn 1969b, 1969c; Lemp 1973).
Several mechanisms have been suggested to explain 
this phenomenon, which is still not completely understood. 
According to the traditional hypothesis, tear disruption 
occurs when lipids diffuse and absorb to the mucous-
aqueous interface (Holly and Lemp 1971); this view, 
however, has been criticized for several reasons (Johnson 
and Murphy 2004). Alternatively, tear break-up may be 
initiated by the rupture of the mucous layer at its thin-
nest spots, allowing the aqueous to come in contact with 
exposed patches of epithelium (Sharma and Ruckenstein 
1985). The tear meniscus-induced thinning of the precor-
neal ﬁ  lm may accelerate tear break-up (McDonald and 
Brubaker 1971).Clinical Ophthalmology 2008:2(1) 41
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Norn and Lemp also described a second phenomenon 
where dry spots were noticed in the precorneal tear ﬁ  lm 
immediately after lid opening. This was referred to as a 
wetting time of zero (Norn 1969b, 1969c; Lemp 1973). 
Pﬂ  ugfelder et al interpreted this second phenomenon as a 
deﬁ  ciency in the mucin layer of the tear ﬁ  lm (Pﬂ  ugfelder 
et al 1998).
Several drugs like antihistamines, antidepressants, anti-
hypertension or Parkinson medications as well as ocular 
surface manipulation affect the TBUT (Lemp and Hamill 
1973). Furthermore, surgical procedures (ie, LASIK) and 
eyelid abnormalities affect tear ﬁ  lm stability. Interest-
ingly, some authors have shown that even the application 
of ﬂ  uorescein shortens the TBUT (Mengher et al 1985a), 
although other authors did not conﬁ  rm this ﬁ  nding (Cho 
et al 1996).
Despite being widely applied for both clinical and 
research purposes, TBUT has been criticized and labeled 
as inaccurate and not reproducible (Vanley et al 1977). The 
large range of normal values, the lack of a standardized pro-
cedure for applying ﬂ  uorescein to the tear ﬁ  lm and the poor 
association with subjective symptoms have further reinforced 
this concept (Nichols, Nichols, et al 2004, Lin et al 2005).
In the clinical setting TBUT can be carried out with the 
help of a moistened ﬂ  uorescein strip or by instillation via 
pipette of 1–5 μL of a 0.5–1% sodium ﬂ  uorescein solution, 
with the use of a yellow barrier ﬁ  lter in the biomicroscope 
to increase contrast. Video imaging of tear ﬁ  lm ﬂ  uorescence 
has been used to map and measure the area of the tear ﬁ  lm 
break-up and seems a promising tool to differentiate between 
healthy and dry eye (Liu et al 2006).
The volume of ﬂ  uorescein delivered to the tear ﬁ  lm is 
likely to be the main source of variability in TBUT val-
ues; consistently, Johnson and Murphy showed that larger 
amounts of ﬂ  uid lengthen its duration (Johnson and Murphy 
2005a), and other studies demonstrated that measurement 
reliability is increased when 2μL or less of ﬂ  uorescein is 
applied with a laboratory micropipette versus the conven-
tional strip method (actually it is unclear whether this result 
is due to the fact that the volumes were small or simply 
standardized) (Foulks 2003, Marquardt et al 1986). Johnson 
and Murphy also reported that a single moistened ﬂ  uorescein 
strip delivers un unpredictable amount of ﬂ  uid, even when the 
ﬂ  uorescein strips are shaken to remove excess ﬂ  uid (Johnson 
and Murphy 2005a); previous studies on RB found that this 
volume is about 17μL of ﬂ  uid (Snyder and Paugh 1998), 
Figure 4 Tear break-up time assessed by ﬂ  uorescein.Clinical Ophthalmology 2008:2(1) 42
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which is considerably larger than the total volume of the 
tear ﬁ  lm (about 7μL) (Mathers et al 1996) and can induce 
a disruptive effect on it. If a micropipette is not available, 
speciﬁ  cally designed narrower strips (Dry Eye Test, Akorn 
Inc., Buffalo Grove, IL) can be adopted in order to deliver 
a small amount of ﬂ  uorescein solution to the ocular surface 
(Korb et al 2001).
Another important confounding variable is inadvertent 
prior or simultaneous instillation of preservatives (such as 
benzalkonium chloride) that, being surface active agents, 
may shorten tear break-up time. The concentration of the 
ﬂ  uorescein is also important because too concentrated a 
solution can result in a very dark ﬂ  uorescein pattern, which 
is difﬁ  cult to evaluate.
Given the intrinsic invasiveness of conventional TBUT 
and its effects on the reliability of the measurements, 
several noninvasive tear break-up time (NITBUT) tests 
have been developed. Their advantage is that they do not 
alter the ocular surface, which means a reduction in irrita-
tion and reﬂ  ex tearing. Mengher described a NITBUT test 
where an illuminated rectangular grid pattern is projected 
onto the corneal surface, which is viewed through the slit 
lamp (xeroscope) (Mengher et al 1985b). The time until 
a distortion of the grid pattern occurs reﬂ  ects the tear 
break-up time. Subsequently, other instruments have been 
used to measure the NITBUT, such as the Tearscope Plus 
(Windsor, Berks, United Kingdom), the DR-1 (Kowa Co. 
Ltd, Japan), or other prototypes (Nichols et al 2002; Yokoi 
and Komuro 2004; Wang et al 2005). All these methods, 
however, have not yet found a wide acceptance in clini-
cal practice due to problems in quantiﬁ  cation (Dogru and 
Tsubota 2004), considerable between-examiner variability 
(Cho and Douthwaite 1995; Nichols et al 2002) or sim-
ply because the required technology rarely is available. 
Many studies using both NITBUT and ﬂ  uorescein TBUT 
have been undertaken on normal controls and dry eye 
patients. In normal control eyes the values of the ﬂ  uo-
rescein TBUT can range from 3 to 132 seconds, with an 
average of 27 seconds (Norn 1969b). In dry eye patients, 
TBUT is reduced to mean values lower than 5 seconds, 
but the interindividual variability is still high (Pﬂ  ugfelder 
et al 1998; Uchino et al 2006). Although patients with 
ATD show lower TBUT values than those with MGD, a 
differential diagnosis of these two entities is difﬁ  cult to 
make based on TBUT alone because of largely overlapping 
values (Pﬂ  ugfelder et al 1998). Nor is TBUT associated 
with Meibomian gland changes in asymptomatic patients 
(Den et al 2006).
When measured in the same sample, TBUT and NITBUT 
poorly correlate, the latter being longer than the former (Cho 
and Douthwaite 1995; Nichols et al 2002). Regarding the 
NITBUT test, mean values in normal subjects were reported 
to be around 11 seconds; Mengher reported an approximately 
30% decrease in dry eye patients compared to normal 
subjects (Mengher et al 1985b; Cho and Douthwaite 1995; 
Nichols et al 2002). Using a xeroscope, he found some tear 
ﬁ  lm irregularity patterns in a signiﬁ  cantly higher number 
of patients with ATD – especially SS patients – compared 
to normal controls or those with MGD. These patterns 
were described as immediate irregular tear ﬁ  lm distortions 
after a complete blink. He further hypothesized that the 
xeroscope can be effectively used to assess the integrity of 
the precorneal mucin layer.
Despite the wide variation in TBUT among individual 
subjects, there is general agreement that a TBUT shorter 
than 10 seconds reﬂ  ects tear ﬁ  lm instability, whereas a 
TBUT shorter than 5 seconds is a marker of deﬁ  nite dry eye 
(Shimazaki 1995). TBUT is both an easy to perform test 
and a valuable diagnostic aid in the assessment of ocular 
surface disorders. According to Plugfelder et al it should 
be performed at the beginning of the diagnostic algorithm 
and should precede other invasive diagnostic measures like 
ocular pressure measurement or pupil dilation (Pﬂ  ugfelder 
et al 1998). However, if noninvasive tests (such as tear ﬁ  lm 
interferometry or meniscus height measurement) are planned, 
these should be performed ﬁ  rst as they may be altered by 
ﬂ  uorescein instillation.
Several questions about TBUT are still unanswered 
and warrant further study: which method of ﬂ  uorescein 
delivery produces the most reliable results in terms of both 
repeatability and sensitivity/speciﬁ  city in detecting dry eye? 
What is the meaning of different TBUT patterns (eg, central 
vs. peripheral dry spots)? Is it possible to deﬁ  ne a cut-off 
value for ATD and/or MGD?
Tear ﬁ  lm stability analysis system 
(TSAS) and other technologies
to assess the tear ﬁ  lm stability
In addition to the above-mentioned methods of TBUT 
and NITBUT evaluation, some technologies not primarily 
developed for this purpose have been used to assess the tear 
ﬁ  lm stability. In 1999, Liu and Pﬂ  ugfelder, for example, 
were able to differentiate between dry and non-dry eyes by 
means of the TMS-1 corneal topography system (Liu and 
Pﬂ  ugfelder 1999). Later Nemeth and colleagues performed Clinical Ophthalmology 2008:2(1) 43
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consecutive measurements of corneal topography to measure 
tear ﬁ  lm build-up time for normal and dry eye patients 
(Nemeth et al 2002).
More recently the Tear ﬁ  lm Stability Analysis System 
(TSAS) (Figure 5) was developed for this purpose. It allows 
the clinician to record consecutive topographic images 
every second for 10 seconds, thus deriving several quan-
tiﬁ  cation indices. Kojima et al used the surface regularity 
index (SRI) and surface asymmetry index (SAI), while 
Goto et al studied additional indices, namely TMS-BUT 
and TMS-BUA (Goto T et al 2003; Kojima et al 2004). 
TMS-BUT is a measure of the time it takes for the ocular 
surface to change its refractive power by 0.5 diopters 
after each blink. TMS-BUA represent the area where the 
break-up time is less than or equal to 5 seconds. In dry eye 
patients, a gradual increase in SRI and SAI (especially in 
non-SS ATD), reduction in TMS-BUT and higher values of 
TMS-BUA have been reported (Goto T et al 2003; Kojima 
et al 2004). The commercially available TSAS system is 
built in an autorefractometer (RT-6000, TOMEY, Nagoya, 
Japan). It has a potential to be widely used for dry eye 
screening, especially in mild cases, while its utility may be 
limited in patients with reﬂ  ex tear secretion during forced 
eye opening. A deﬁ  nition of normal values for differently 
aged groups and diagnostic criteria are still lacking and this 
area warrants further research.
Among the other technologies adopted to evaluate the 
tear ﬁ  lm stability, wavefront aberrometry and laser scan-
ning microscopy should be remembered. The rationale for 
using wavefront aberrometry is based on the notion that 
tear break-up induces optical changes in the eye that can 
result in highly degraded retinal image quality and reduced 
spatial vision (Tutt et al 2000). Consistently, aberrometry 
has showed that tear ﬁ  lm disruption increases corneal and 
total higher order aberrations in both normal and dry eyes 
(Montés-Micó et al 2004; Lin et al 2005).
Laser scanning microscopy has been investigated as a 
tool to observe the tear ﬁ  lm at high magniﬁ  cation, leading 
to the morphological representation of TBUT phenomena 
(Torens et al 2000).
Functional visual acuity
Patients with clinically dry eye are likely to complain of 
decreased visual acuity during tasks such as reading, driv-
ing and visual display terminal (VDT) work (Tsubota and 
Nakamori 1993; Goto, Yagi, et al 2002). When these activities 
are carried out, the act of gazing suppresses the blink rate; as 
a consequence desiccation of the ocular surface occurs, thus 
impairing visual acuity (accordingly, Tsubota et al reported 
that dry eye patients blink twice as much (33.9/min) as normal 
controls (14.3/min) under relaxed conditions: the increased 
blink rate is thought to compensate for the tendency of the ocu-
lar surface to dry out by reducing tear evaporation and creating 
a new tear ﬁ  lm layer with each blink) (Tsubota and Nakamori 
1993; Tsubota, Hata et al 1996; Nakamori et al 1997).
Several studies support the concept that an unstable tear 
ﬁ  lm affects visual acuity(Rieger 1992; Rolando et al 1998; 
Chen and Wang 1999; Liu and Pﬂ  ugfelder 1999; Tutt et al 
2000). As previously stated, the increase of higher order 
aberrations is the main reason for decreased visual perfor-
mance (Tutt et al 2000; Montés-Micó et al 2004; Lin et al 
2005). Importantly, it was reported that such impaired vision 
improved after punctal occlusion, even in severe dry eye 
cases with chronic Stevens-Johnson syndrome (Ozkan et al 
2001; Kaido et al 2004).
To evaluate dynamic visual function representative of 
daily activities, Goto and colleagues developed the func-
tional visual acuity (FVA) measurement system (Goto, 
Ishida, et al 2006). Initially, they carried out the visual 
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Figure 5 Representative TSAS data of patients with mild (A), moderate (B) and 
severe damage of tear ﬁ  lm stability (C). Graph shows the consecutive changes in 
SRI (surface regularity index, blue line) and SAI (surface asymmetry index, red line).Clinical Ophthalmology 2008:2(1) 44
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acuity measurements using conventional Landolt charts, by 
elevating the patients’ upper eye lids manually for 10~20 
seconds (Goto, Yagi et al 2002). In that study ordinary best-
corrected visual acuity and FVA were measured in non-SS 
and SS patients and in normal controls. The SRI of corneal 
topography was also measured under routine circumstances 
and after 10 seconds of sustained eye opening. Compared to 
the conventional best-corrected visual acuity, FVA did not 
change in normal controls, but decreased in non-SS patients 
and SS patients (Figure 6 left pane). The SRI after sustained 
eye opening increased in non-SS and SS patients, but not in 
the normal controls (Figure 6 right pane). The study showed 
that the visual function of dry eye patients became abnormal 
with ocular surface irregularity when the eye was kept open 
for 10–20 seconds. (Goto, Yagi et al 2002).
This measurement method was then applied to evaluate 
punctal plug insertion in dry eye subjects (Goto, Yagi, et al 
2003). FVA after punctal plug insertion was signiﬁ  cantly 
higher than in patients without a punctal plug (Figure 7).
The drawback of this FVA measurement method was the 
uncertainty of the timing. To improve FVA measurements 
a new continuous functional visual acuity measurement 
system (FVAM, SSC-350®, NIDEK, Gamagori, Japan) was 
developed (Ishida et al 2005) (Figure 8). This compact device 
allows continuous monocular visual acuity measurement dur-
ing a 30 second blink-free period. The screen onto which the 
Landolt C optotypes are projected within the device measures 
25.8 cm x 33.8 cm. Each Landolt C optotype presented at a 
certain visual acuity level subtends an angle equivalent to 
the optotype of the same visual acuity level presented at a 
distance of 5 meters during conventional Landolt C visual 
acuity testing.
In Ishida’s study, visual acuity was measured with no 
restraints of blinking using this instrument (baseline FVA). 
Five minutes after instillation of topical anesthesia, patients 
were instructed not to blink for 30 seconds. Functional 
visual acuity at 10 seconds, 20 seconds, and 30 seconds were 
measured and compared between the patients and control 
subjects. FVA in dry eyes was signiﬁ  cantly lower than in 
the controls at all time points and signiﬁ  cantly improvedafter 
punctal plug insertion.
Tear meniscus assessment
The tear meniscus (TM) is the amount of tears that lies at 
the junction of the bulbar conjunctiva of both the upper and 
lower eyelid margins. From a physical point of view, the term 
“meniscus” refers to a curve (either concave or convex) in the 
surface of a liquid within a container. Menisci are generated 
by an imbalance between the cohesion of ﬂ  uid molecules 
to each other (surface tension) and the adhesion of these 
molecules to the adjacent solid surface. When the former is 
lower than the latter, as in the case of tears, the ﬂ  uid works 
to maximize the contact surface area. As a result, the TM, 
when viewed in cross section, always has a concave proﬁ  le; 
Figure 6 Visual acuity and SRI at ordinary free blinking and after sustained eye opening in dry eye patients and normal controls. Left Pane: Functional visual acuity decreased 
signiﬁ  cantly in the non-SS and SS groups compared to normal controls. Right pane: the SRI recorded after sustained eye opening increased signiﬁ  cantly in the non-SS and SS 
groups compared to normal controls. Non-SS - non-Sjögren’s syndrome type dry eye, SS - Sjögren’s syndrome patients, Control – normal controls, BCVA - best-corrected 
visual acuity (decimal notation), FVA – functional visual acuity (decimal notation), SRI - surface regularity index of corneal topography, 10s SRI – SRI recorded after 10 sec-
onds of sustained eye opening. Reprinted from Goto et al, Optical Aberrations and   Visual Disturbances Associated With Dry Eye, The Ocular Surface -2006-4-page 208 with 
the permission of the authors and Ethis Communications.
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Figure 7 Visual Acuity and SRI during ordinary free blinking and after sustained eye opening in dry eye patients and dry eye patients with punctal plug. Left pane: ordinary 
BCVA in ATD patients was 1.16 and that in ATD patients with punctal plug was 1.22 (P = 0.6). On the contrary, FVA in ATD was 0.283 and that in ATD with punctal plug 
was signiﬁ  cantly higher, 0.962 (P < 0.0001). Functional visual acuity decreased signiﬁ  cantly only in ATD without punctal plug, and remained within the normal range in ATD 
with punctal plug.  Right Pane: the SRI recorded after 10 seconds of sustained eye opening (10 sec SRI) increased in both groups. 10 sec SRI was signiﬁ  cantly lower in ATD 
with punctal plug. ATD – aqueous tear deﬁ  ciency dry eye, ATD PO - aqueous tear deﬁ  ciency dry eye after the treatment with punctal plug insertion, BCVA - best-corrected 
visual acuity (decimal notation), FVA – functional visual acuity (decimal notation), SRI - surface regularity index of corneal topography, 10s SRI – SRI recorded after 10 sec-
onds of sustained eye opening. Reprinted from Goto et al, Optical Aberrations and Visual Disturbances Associated With Dry Eye, The Ocular Surface -2006-4-page 209 with 
the permission of the authors and Ethis Communications.
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Figure 8 Example of FVA measurement result using FVAM System. Left Pane: normal control. a; Best-corrected visual acuity. b; FVA was 0.8 at 10.8 seconds of sustained eye 
opening. c; Response time. d; FVA was 0.8 at 60 seconds of sustained eye opening. Right pane: dry eye subject. e; Best-corrected visual acuity. f; FVA was 0.63 at 9.8 seconds 
of sustained eye opening. g; FVA was 0.1 at 39.1 seconds of sustained eye opening. Reprinted from Goto et al, Optical Aberrations and Visual Disturbances Associated With 
Dry Eye, The Ocular Surface -2006-4-page208 with the permission of the authors and Ethis Communications. Clinical Ophthalmology 2008:2(1) 46
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this curved surface in turn tends to suck ﬂ  uid back from the 
precorneal ﬁ  lm into the meniscus (Tiffany 2006).
The TM is present in both the upper and lower eyelids; 
while some authors did not detect signiﬁ  cant differences as 
far as height, area and curvature of both menisci are con-
cerned (Wang et al 2006), others found some differences 
in tear meniscus height (TMH) and curvature (Creech et al 
1998; Johnson and Murphy 2006). However, the great major-
ity of studies have focused only on the lower TM, mainly 
because of the relatively high mobility of the upper eyelid 
and obscuration produced by the upper eyelashes.
Evaluation of the TM is usually aimed at obtaining 
quantitative measurements, but a qualitative assessment is 
also important.
Conventionally, the TM is examined at the slit-lamp 
using a calibrated variable slit beam height; equipping the 
slit lamp with a micrometer allows the clinician to obtain 
more accurate measurements (Lamberts et al 1979; Miller 
et al 2004; Nichols, Nichols et al 2004). Micrometers can 
provide estimations with an accuracy of up to 0.03 mm and 
represent the cheapest and simplest method to measure the 
TMH. The main drawback of slit-lamp examination is that 
it cannot always easily identify the TM. Visibility can be 
improved by instillation of ﬂ  uorescein (Oguz 2000). Since 
enhancement by ﬂ  uorescein may interfere with the tear 
meniscus volume (especially if ﬂ  uorescein strips are wetted 
with one drop of saline or balanced salt solution), it has been 
suggested that the TM should be evaluated ﬁ  ve minutes after 
the ﬂ  uorescein strip has been applied (Lim and Lee 1991; 
Oguz et al 2000).
In order to overcome the possible bias introduced by 
ﬂ  uorescein instillation and obtain more accurate measure-
ments, several authors have recently developed a variety of 
methods to noninvasively study and quantify the TM; these 
include photography (Mainstone et al 1996; Santodomingo-
Rubido and Wolffsohn 2006), video recording (Doughty et al 
2001, 2002; Glasson et al 2003), reﬂ  ective meniscometry 
(Yokoi, Bron et al 1999; Oguz et al 2000), optical coherence 
tomography (OCT) (Figure 9) (Johnson and Murphy 2005; 
Savini et al 2006b; Wang et al 2006), tear interference imag-
ing by Tearscope (Uchida et al 2007), optical pachimetry and 
strip meniscometry (Johnson 2005; Dogru 2006). Although 
some of these techniques can provide measurements accurate 
to within 0.01 mm, in most cases the acquisition process is 
laborious, as it may involve either expensive (eg, OCT) or 
commercially unavailable instruments (eg, videomeniscom-
etry), as well as speciﬁ  c applications (eg, Adobe Photoshop 
or similar) to analyze the captured images.
The most commonly measured parameter is TMH. 
Another parameter that has received considerable attention is 
the tear meniscus radius, which has been shown to be an index 
of total tear volume (Yokoi et al 2004). Imaging techniques 
providing a cross-sectional view of the tear meniscus also 
allow the assessment of tear meniscus depth and area.
The main limit of tear meniscus assessment is the lack 
of universally accepted normative data and cut-off values 
for normal eyes. Mean TMH values range from 0.12 ± 0.04 
to 0.46 ± 0.17 mm in healthy eyes and from 0.13 ± 0.07 
Figure 9 Cross-sectional imaging of the tear meniscus obtained by optical coher-
ence tomography.Clinical Ophthalmology 2008:2(1) 47
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to 0.24 ± 0.09 in the case of dry eye (see Table 3). 
Nichols used a cut-point of less than 0.3 for classifying an 
abnormal TMH (Nichols, Nichols, et al 2004). Doughty 
suggested cut-off values of 0.1 and 0.25 mm (Doughty 
et al 2002); however, Lamberts reported that a TMH of 
0.1 mm or less could be found in 7% of normal eyes (Lamberts 
et al 1979). Recently Patel and Wallace evaluated TMH in 
a very large sample, including 440 normal subjects aged 
between 6 and 91. They found a mean value of 0.19 ± 0.1 in 
both males and females, with higher measurements in older 
patients (related to the increasing rate of lacrimal puncta 
stenosis). According to this study, the mean TMH, when 
stratiﬁ  ed for age, was the following: 0–20 years = 0.15 ± 
0.06 mm; 21–40 years = 0.15 ± 0.06 mm; 41–60 years = 
0.17 ± 0.08 mm; 61–80 years = 0.20 ± 0.12 mm; over 80 
years = 0.21 ± 0.1 mm (Patel and Wallace 2006). Regret-
tably, notwithstanding the considerable sample size, these 
authors did not provide any cut-off value; indeed, according 
to their data it seems quite hard to determine such a value, 
since many “normal” eyes showed a TMH lower than 
0.1 mm. The difﬁ  culties may be increased even further 
if we consider that (1) TMH is not a static parameter, but 
rises after each blink due to capillary forces (for this reason 
Johnson and Murphy recently recommended that all mea-
surements should be performed 3–4 seconds after a blink) 
(Johnson and Murphy 2006), (2) a given increase in the tear 
volume does not actuate an identical increase in TMH in 
all individuals, presumably because of an interindividual 
variability in horizontal and anterior-posterior meniscus 
dimensions (Johnson and Murphy 2006) and (3) TMH 
seems to depend on the palpebral aperture height and thus 
the exposed ocular surface (Doughty et al 2001).
Further investigations are needed (1) to determine whether 
it is possible to deﬁ  ne a cut-off value between healthy and 
dry eyes; (2) to elucidate any association between TMH (or 
other TM parameters) and dry eye symptoms; (3) to assess 
what Lamberts and colleagues suggested almost thirty years 
ago, ie, the inﬂ  uence of blink rate, length of the lower lid, 
position of the Meibomian glands and lid-globe apposition 
on TMH (Lamberts et al 1979).
Qualitative assessment of the tear meniscus has the same 
importance as quantitative measurement of its parameters, 
but has rarely been used in clinical studies. A simple method 
is still represented by ﬂ  uorescein staining and subsequent 
photography: this approach was followed, for example, by Di 
Pascuale in evaluating the inﬂ  uence of conjunctivochalasis on 
the ocular surface (Di Pacuale, Espana, et al 2004). It allows 
the clinician to detect obliteration or disruption of the tear 
meniscus. Alternatively, Guillon described how the Tearscope 
can be used to visualize the tear meniscus and grade its height, 
regularity and continuity (Guillon 1998). Qualitative analysis 
can be biased by its subjective nature, but is important in that 
it gives unique information from a clinical point of view.
Tear ﬁ  lm interferometry
Tear interferometry is a noninvasive method that can be 
used to visualize the lucent surface of the tear ﬁ  lm lipid 
layer (Doane 1989; Goto, Dogru, et al 2003). Tear inter-
ference images were ﬁ  rst analyzed by McDonald in 1968 
while observing the surface phenomena of the tear ﬁ  lm 
and received considerable attention during the following 
years (McDonald 1968; Norn 1979; Guillon 1982; Olsen 
1985; Bron and Tiffany 1998). The interference phenom-
ena inferred from the tear ﬁ  lm indicate the presence of a 
thin ﬁ  lm, which is the lucent superﬁ  cial tear lipid layer 
(Figure 10). The color of these interference images depends 
on the presence and thickness of the lipid ﬁ  lm (Norn 1979; 
King-Smith et al 1999), which in turn affects both tear 
Table 3 Lower tear meniscus height as reported in the peer-reviewed literature
Author (year)  Method of TMH assessment  Mean TMH for healthy eyes (mm)  Mean TMH for dry eyes (mm)
Miller et al (2004)  Slit-lamp  0.25 ± 0.04  –
Patel and Wallace (2006)  Slit-lamp  0.19 ± 0.1  –
Nichols et al (2004a)  Slit-lamp  –  0.29 ± 0.13
Santodomingo- Rubido  Slit-lamp  0.12 ± 0.05  –
and Wolffsohn (2006)  Photography  0.13 ± 0.04  –
Mainstone et al (1996)  Optic section photography + ﬂ  uorescein  0.46 ± 0.17  0.24 ± 0.08
Doughty et al (2002)  Video recording  0.18 ± 0.08  –
Oguz et al (2000)  Slit-lamp + ﬂ  uorescein  –  0.21 ± 0.14
  Cross-sectional photography + ﬂ  uorescein  –  0.24 ± 0.09
Savini et al (2006)  StratusOCT  0.25 ± 0.08  0.13 ± 0.07
Wang et al (2006)  Real-time OCT  0.25 ± 0.07  –
Johnson and Murphy  OCT-1  0.27  –
(2005)  Optical pachimetry (cross section)  0.33 Clinical Ophthalmology 2008:2(1) 48
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evaporation and eye lubrication during blinking (Tiffany 
1987; Lemp 1995; Driver and Lemp 1996). When the lipid 
layer is intact, evaporation represents a small loss of water 
for which the lacrimal gland easily compensates (Mathers 
2004), but if it is absent or incomplete, a four-fold increase 
in evaporation occurs (evaporation, however, does not seem 
to be inﬂ  uenced by the thickness of the lipid layer) (Craig 
and Tomlinson 1997).
During examinations for dry eye diagnosis, interferom-
etry has been used with a color-comparison table to derive 
lipid layer thickness (Korb et al 1994; Korb and Greiner 
1994; Isreb et al 2003) or with the semi-quantitative severity 
grade scoring system for Sjögren’s syndrome and dry eye 
syndrome (Danjo and Hamano 1995; Yokoi et al 1996).
DR-1 tear interference camera
Since McDonald’s ﬁ  rst report, several tear interference imag-
ing devices have been developed; the DR-1® tear interference 
camera (Kowa Co., Nagoya, Japan) is currently considered 
the most sophisticated system, as it clearly shows the image 
while eliminating the background iris color and central image 
defects (Yokoi et al 1996; Goto and Tseng 2003a).
Since tear interference color has been known to indicate 
lipid ﬁ  lm thickness, several trials have been performed with 
the aim of quantifying interference images (Norn 1979; Guil-
lon 1982; Korb and Greiner 1994; Doane 1998; King-Smith 
et al 1999; Khamene et al 2000).
Using a DR-1, Yokoi et al were able to associate the 
severity of ATD with the interference pattern produced by the 
tear ﬁ  lm lipid layer. Tear interference images were graded as 
follows: grade 1, somewhat gray color, uniform distribution; 
grade 2, somewhat gray color, non-uniform distribution; 
grade 3, a few colors, non-uniform distribution; grade 4, 
many colors, non-uniform distribution; grade 5, corneal sur-
face partially exposed. Grades higher than 3 were observed 
in dry eye subjects, and grades 1 and 2 were seen in both 
Figure 10 DR-1 tear interference image of Sjogren syndrome patient. A tear interference image of Sjogren syndrome patient (60 years old Asian female). The tear lipid 
layer is visualized over a corneal area with a diameter of approximatively 8 mm. On the lower corneal area, the thickened tear lipid can be seen in a colorful interference 
images. On the contrary, in the upper corneal area, a thin and deﬁ  cient lipid layer can be observed with dark interference color. Such an unevenly distributed lipid could be 
caused by the deﬁ  ciency of the aqueous tear component in the Sjogren syndrome patients.Clinical Ophthalmology 2008:2(1) 49
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normal and dry eye subjects (Yokoi et al 1996; Yokoi, Mossa, 
et al 1999).
More recently, Goto et al reported a method for the 
quantiﬁ  cation of precorneal tear lipid layer thickness in 
which they generated a computer-synthesized tear interfer-
ence color chart for the DR-1 camera by image analysis and 
a colorimetric approach (Goto, Dogru, et al 2003). Using 
this system, tear lipid layer thickness could be estimated and 
plotted on the interference image as a topographic presenta-
tion. This lipid layer quantiﬁ  cation method seeks to assess 
the mechanism of ocular dryness based on a direct evaluation 
of the procorneal tear lipid layer as well as an evaluation of 
meibomiam gland status.
DR-1 grading is practically useful. Thus an attempt 
should be made to understand the association between grad-
ing and lipid layer thickness. Grades 1 and 2 could indicate 
lipid layer thickness from very thin to approximately 100 nm, 
which can be considered physiological. In normal healthy 
subjects lipid layer thickness is reported to be around 70 nm 
and the interference fringe pattern is horizontal (Goto and 
Tseng 2003a). Grades 1 and 2 have also been observed in 
MGD subjects showing a dark interference color without 
any fringe or with a vertical pattern (Goto and Tseng 2003a). 
Dry eye with only a decreased tear break-up time or mild 
ATD dry eye could be also included in this color range (Goto 
2004). Grades 3 and 4 indicate that the lipid layer thickness 
is greater than 130 nm and lipid distribution is non-uniform. 
Deﬁ  cient aqueous production may cause the lipid layer to 
be undistributed and this abnormal distribution could be 
remedied by increasing the water volume through punctal 
occlusion (Goto and Tseng 2003b). Grade 5 is a dark inter-
ference color and indicates an almost complete absence of 
lipids on the ocular surface.
Kinetic analysis of tear interference 
images
With lid blinking, meibomian lipids spread from the lower 
lid margin to the upper area of the cornea. Tear interference 
imaging devices such as the DR-1 camera or the Tearscope 
(Keeler, Windsor, UK) can clearly visualize these lipid 
movements. Goto and Tseng reported a kinetic analysis of 
tear lipid layer interference images, which they had recorded 
with a DR-1 camera. They measured the lipid spread time 
(LST), ie, the time between eye opening and the end of 
lipid spread. In normal subjects, lipids spread quickly to the 
upper cornea in a horizontal wavy pattern, with a mean LST 
of 0.36 seconds. In subjects with lipid deﬁ  ciency due to dry 
eye with MGD, lipids spread slowly (LST = 3.5 seconds) 
with a vertical streaking pattern (Goto and Tseng 2003a). 
In ATD dry eyes, mean LST was 2.2 seconds and the lipids 
did not spread as far as the upper area of the cornea. After 
punctal occlusion LST decreased to 0.8 seconds and the 
lipid spread reached the upper area of the cornea (Goto and 
Tseng 2003b). As noted previously, LST was useful for the 
purpose of differentiating dry eye subtypes and quantitatively 
evaluating treatment efﬁ  cacy.
Tear interference images from a DR-1 camera have been 
also used to study the effectiveness of topical treatments 
for dry eye. Traditionally, this syndrome has been treated 
with non-preserved artiﬁ  cial tear eye drops or punctual plug 
insertion, which are aimed at improving the aqueous layer. 
When dry eye is refractory to such a treatment, topical lipid 
therapy may be attempted (Rieger 1990; MacKeen et al 1998; 
Tsubota et al 1999; Goto, Shimazaki, et al 2002, Pearce et al 
2002; Di Pascuale, Goto, et al 2004; Korb et al 2005). Goto 
et al reported successful lipid layer treatment by low-dose 
lipid application on the full-length eyelid margin in ofﬁ  ce 
workers and demonstrated an increase in lipid layer thickness, 
as determined on the basis of DR-1 tear interference images 
(Goto, Dogru, et al 2006).
Tear evaporation assessment
The National Eye Institute in the United States has classiﬁ  ed 
dry eye syndrome into two types: aqueous tear deﬁ  cient dry 
eyes and lipid deﬁ  cient evaporative dry eyes (Lemp1995); the 
term evaporative dry eye has been maintained also in the recent 
Dry Eye Workshop classiﬁ  cation (DEWS 2007). Thus evalu-
ation of tear evaporation has been considered to be important 
in dry eye assessment (Goto, Shimazaki, et al 2002).
Tear evaporation measurements are noninvasive proce-
dures which can be used to assess tear dynamics, differenti-
ate dry eye subcategories and evaluate treatment options 
(Hamano et al 1980; Rolando and Refojo 1983; Tsubota 
and Yamada 1992; Mathers et al 1993; Shinazaki et al 
1995; Shimazaki et al 1998; Goto, Shimazaki et al 2002). 
This kind of examination should be the key to identifying 
the evaporative type of dry eye, a category which includes 
MGD and dry eye associated with video display terminal 
syndrome (Tsubota and Nakamori 1993; Goto, Shimazaki 
et al 2002). Given the dynamic nature of tears (secretion 
from the lacrimal gland, blinking, drainage from the lacrimal 
puncta and evaporation into air), data are measured as tear 
evaporation rates (grams/sec). To date, three measurement 
methods have been proposed: (1) the evaporimeter system, 
where tear evaporation rates are determined from two humid-
ity sensors placed at different heights from the ocular surface Clinical Ophthalmology 2008:2(1) 50
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Figure 11 Instrument setup (A), schematic diagram of the probe to measure tear evaporation (B), and measurement of tear evaporation (C). (A) Counter clockwise from 
the upper left; personal computer with evaporation measurement software, probe, drying unit, gas ﬂ  ow meter, frequency counter, power supply, and air compressor are 
shown. (B) Schematic diagram of the air resource, frequency counter, power supply, and personal computer are also shown. Air is dried during passage through a drying unit 
(20 x 200 mm) containing silica gel. (C) The subject holds the probe as gently as possible without allowing air to leak from the chamber. Reprinted from Goto et al, Tear 
Evaporation Dynamics in Normal and Obstructive Meibomian Gland Dysfunction Subjects, Investigative Ophthalmology and Visual Science –2003; 44 -page534 with the 
permission of the authors and the Association for Research in Visual and Ophthalmology.
(Hamano et al 1980); (2) the closed-chamber system, where 
tear evaporation rates are estimated from the velocity of the 
humidity increase in a closed chamber at a given ambient 
humidity (Rolando and Refojo 1983; Tsubota and Yamada 
1992; Mathers et al 1993); and (3) the ventilated chamber 
system, where the evaporimeter consists of an eyecup in 
the form of a ventilated chamber, tightly covering the eye; 
air with known water content is infused into the cup as a 
tear evaporation carrier by an air compressor at a constant 
ﬂ  ow rate (Figure 11) (Goto, Endo et al 2003). The reported 
tear evaporation rates in several dry eye conditions are 
summarized in Table 4. Depending on instrument setup, 
evaporation rates from ATD dry eyes have been reported to 
be lower (Hamano et al 1980; Tsubota and Yamada 1992) 
or higher (Rolando and Refojo 1983; Mathers et al 1993) 
than in normal subjects. MGD patients, by contrast, have 
always been found to have higher evaporation rates than 
normal subjects (Shimazaki et al 1995, 1998; Mathers et al 
1993; Goto, Endo et al 2003). To obtain more consistent 
ﬁ  ndings, data comparison should be performed using the 
same instrument setup.
Since dry eye treatment does not yet fully satisfy a large 
amount of patients, the various aspects of dry eye pathophysi-
ology, including evaporation, warrant further investigation. 
Noninvasive assessment of tear evaporation rates provides 
data that are useful not only for making a diagnosis but also 
for evaluating the effectiveness of treatments such as thermo-
therapy or lipid eye drops (Craig and Tomlinson 1997; Goto, 
Monden et al 2002; Goto, Shimazaki et al 2002).
Tear osmolarity
In patients with dry eye the impaired balance between tear 
secretion, evaporation and clearance leads to an increase in 
tear osmolarity, which is considered one of the major sources 
of discomfort, ocular surface damage and inﬂ  ammation. How-
ever, difﬁ  culties in measuring tear osmolarity have hampered 
its acceptance and general application in clinical practice. The 
technique most commonly used to measure tear osmolarity is 
to observe the changes in the freezing point of tear samples. 
The major beneﬁ  t of this technique is that it requires only 
microliter samples of tears (~0.2 μL). The drawbacks of the 
technique include the fact that it requires specialist expertise, 
the equipment must undergo constant maintenance, the pro-
cedure itself is lengthy and entails a cumbersome laboratory 
setup and errors may potentially occur due to evaporation of 
the test sample or reference standards.
Alternative methods include indirect assessment 
through measurement of the electrical conductivity of tear 
samples – which offers the advantage of real-time, in-situ 
determination of tear osmolarity, but requires a large sample Clinical Ophthalmology 2008:2(1) 51
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size and may cause reﬂ  ex tearing since a sensor is placed on 
the ocular surface - and a new osmometer (OcuSense, Los 
Angeles, CA) which requires 0.2-μL samples of tears placed 
into a disposable microelectrode array for semiautomatic 
reading of osmolarity.
A recent meta-analysis found a cut-off value of 315.6 
mOsmol/L between healthy and dry eyes. This value showed 
an overall predictive accuracy of 89% for the diagnosis of dry 
eye syndrome; however a large rate (41%) of false negatives 
could still be expected (Tomlinson et al 2006). The difﬁ  cul-
ties in making a reliable assessment are the consequence of 
overlapping levels between normal and dry eye.
Conclusions
After more than 100 years of research, the diagnosis of 
dry eye is still a challenging task in many cases. Several 
factors contribute to making diagnosis difficult and 
warrant further attention: the invasiveness and low degree 
of standardization of most conventional tests (Schirmer, 
TBUT and ocular surface staining), the still incomplete 
knowledge about the pathophysiology underlying the 
phenomena measured by some of these tests (eg, TBUT) 
and the overlapping of dry eye symptoms with those of 
other conditions, such as conjunctivochalasis (which 
can easily induce an unstable tear ﬁ  lm) or delayed tear 
clearance (which is a frequent cause of ocular irritation). 
Newer noninvasive tests are still conﬁ  ned to a few centers 
devoted to clinical research, either because they require 
expensive instruments or because of their complexity. The 
low agreement found in some studies between subjective 
symptoms and objective tests reﬂ  ects our difﬁ  culties in 
making a diagnosis of dry eye; however, it should also 
stimulate us to persevere in our clinical research efforts 
with the aim of identifying which combination of tests has 
the best predictive accuracy for both ATD and MGD, the 
two most important major causes of dry eye. Satisfactory 
results are unlikely to be achieved as long as investigations 
are limited to assessing the tear ﬁ  lm and fail to consider 
the ocular surface as a functional unit, a concept that 
was clearly propounded by Tseng and Tsubota ten years 
ago (Tseng and Tsubota1997). For this to occur, future 
studies should also include an evaluation of factors such 
as frequency and quality of blinking, corneal sensitivity, 
ocular surface exposed area, status of lacrimal puncta 
and coexistence of conjunctivochalasis or delayed tear 
clearance, which may have all a signiﬁ  cant impact on both 
subjective and objective parameters.
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